Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 94 Neoplasm Metastasis 9 Prostatic Neoplasms, Castration-Resistant 5 Breast Neoplasms 3 Neoplasms 2 Metastatic Castration Resistant Prostate Cancer 2 Castration-resistant Prostate Cancer 2 Urinary Bladder Neoplasms 1 Stage II Prostate Adenocarcinoma 1 Salivary Glands Tumors 1 Rate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone 1 Prostate Cancer Metastatic 1 Prostate Adenocarcinoma 1 Pharmacogenetic Study 1 Oligometastatic Prostate Carcinoma 1 Neoadjuvant Therapy 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Metastatic Hormone Refractory Prostate Cancer 1 Metastatic Castration-resistent Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Dementia 1 Cushing Syndrome 1 Cognitive Dysfunction 1 Castrate-resistant Prostate Cancer 1 Carcinoma, Transitional Cell 1 Cancer Pain 1 Adrenocortical Carcinoma 1 Adenocarcinoma 1

Interventions

Mitotane 7 Cisplatin 6 pembrolizumab 5 Etoposide 3 Doxorubicin 3 camrelizumab 2 apatinib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Cytoreduction Surgical Procedures 2 sodium thiosulfate 1 iodophenyl metomidate 1 fludarabine phosphate 1 dostarlimab 1 cemiplimab 1 cabozantinib 1 cabazitaxel 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Suramin 1 Sunitinib 1 Streptozocin 1 Sorafenib 1 Radiation 1 Paclitaxel 1 Observation 1 Nivolumab 1 Megestrol Acetate 1 Lymph Node Excision 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adrenocortical Carcinoma × Abiraterone Acetate × Clear all

NCT03145285 2017-05-10

ABACUS

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Unknown

Cushing Syndrome, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡